Marguerite du Plessis

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.

B. Trock, E. Klein, S. Freedland, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy.

S. Freedland, F. Feng, R. Karnes, 2016, European urology.

Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting.

K. Yousefi, E. Davicioni, V. Choeurng, 2016, The Journal of urology.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

P. Carroll, R. Stoyanova, A. Tewari, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance

B. Trock, E. Klein, E. Davicioni, 2018, Prostate Cancer and Prostatic Diseases.

Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.

F. Feng, E. Davicioni, J. Efstathiou, 2019, European urology.

Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial.

W. Lowrance, A. Kibel, Y. Lotan, 2019, Practical radiation oncology.